Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Reinventing radiation therapy with machine learning and imaging bio-markers (radiomics): State-of-the-art, challenges and perspectives
Radiation therapy is a pivotal cancer treatment that has significantly progressed over the last
decade due to numerous technological breakthroughs. Imaging is now playing a critical role …
decade due to numerous technological breakthroughs. Imaging is now playing a critical role …
Pretreatment prediction of immunoscore in hepatocellular cancer: a radiomics-based clinical model based on Gd-EOB-DTPA-enhanced MRI imaging
Objectives Immunoscore evaluates the density of CD3+ and CD8+ T cells in both the tumor
core and invasive margin. Pretreatment prediction of immunoscore in hepatocellular cancer …
core and invasive margin. Pretreatment prediction of immunoscore in hepatocellular cancer …
Influence of Magnetic Field Strength on Magnetic Resonance Imaging Radiomics Features in Brain Imaging, an In Vitro and In Vivo Study
Background The development and clinical adoption of quantitative imaging biomarkers
(radiomics) has established the need for the identification of parameters altering radiomics …
(radiomics) has established the need for the identification of parameters altering radiomics …
Prediction of histologic neoadjuvant chemotherapy response in osteosarcoma using pretherapeutic MRI radiomics
A Bouhamama, B Leporq, W Khaled… - Radiology: Imaging …, 2022 - pubs.rsna.org
Histologic response to chemotherapy for osteosarcoma is one of the most important
prognostic factors for survival, but assessment occurs after surgery. Although tumor imaging …
prognostic factors for survival, but assessment occurs after surgery. Although tumor imaging …
The role of multimodal imaging in guiding resectability and cytoreduction in pancreatic neuroendocrine tumors: focus on PET and MRI
Pancreatic neuroendocrine tumors (pNETs) are rare neoplasms that secrete peptides and
neuro-amines. pNETs can be sporadic or hereditary, syndromic or non-syndromic with …
neuro-amines. pNETs can be sporadic or hereditary, syndromic or non-syndromic with …
Use of precision imaging in the evaluation of pancreas cancer
RL Korn, S Rahmanuddin, E Borazanci - Precision Medicine in Cancer …, 2019 - Springer
Pancreas cancer is an aggressive and fatal disease that will become one of the leading
causes of cancer mortality by 2030. An all-out effort is underway to better understand the …
causes of cancer mortality by 2030. An all-out effort is underway to better understand the …
Imaging-guided precision medicine in non-resectable gastro-entero-pancreatic neuroendocrine tumors: a step-by-step approach
The majority of gastroenteropancreatic (GEP) neuroendocrine tumors (NETs) are diagnosed
at a non-resectable stage due to non-specific clinical syndromes, late manifestations from …
at a non-resectable stage due to non-specific clinical syndromes, late manifestations from …
3D brachytherapy for cervical cancer: New optimization ways
I Fumagalli, C Haie-Méder, C Chargari - Cancer/Radiothérapie, 2018 - Elsevier
Brachytherapy has known major improvements in recent decades. It represents an essential
component of local treatment of cervix cancers. One major breakthrough was the advent of …
component of local treatment of cervix cancers. One major breakthrough was the advent of …
[PDF][PDF] Фантомы в ядерной медицине
ПО Румянцев, АА Трухин, КА Сергунова… - Медицинская …, 2020 - researchgate.net
РефеРат Разработка фантомов для ядерной медицины основана на
последовательном описании вычислительной и экспериментальной биологических …
последовательном описании вычислительной и экспериментальной биологических …
Prédiction de la réponse à la chimiothérapie des ostéosarcomes à partir des données radiomiques issues des IRM diagnostiques
J Dufau, A Bouhamama, B Leporq, L Malaureille… - Bulletin du …, 2019 - Elsevier
Résumé Introduction L'ostéosarcome est la tumeur osseuse maligne la plus fréquente avant
25 ans. La réponse à la chimiothérapie néo-adjuvante influe la suite du traitement et est un …
25 ans. La réponse à la chimiothérapie néo-adjuvante influe la suite du traitement et est un …